TOPM (Translational Oncotype Prediction Model): Development and Internal Validation of an Interpretable Clinicopathological Model for Pre-Test Estimation of High Oncotype DX Recurrence Score in Early Hormone Receptor–Positive, HER2-negative Breast Cancer